Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshinobu Onuma

Showing results (1-10 of 665) with videos related to

Pageof 67
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2017
Long-term data of BRS presented at EuroPCR 2017 (Friday, 19 May)Patrick W Serruys, Athanasios Katsikis, Yoshinobu Onuma
Expert Review of Medical Devices|May 8, 2009
Xience V everolimus-eluting coronary stentNeville Kukreja, Yoshinobu Onuma, Patrick W Serruys
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 24, 2013
Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trialYoshinobu Onuma, Karine Miquel-Hebert, Patrick W Serruys, et al.
Expert Opinion on Drug Delivery|February 26, 2009
Advances in stent drug delivery: the future is in bioabsorbable stentsJoanna J Wykrzykowska, Yoshinobu Onuma, Patrick W Serruys
Annals of Cardiothoracic Surgery|August 11, 2018
SYNTAX II and SYNTAX III trials: what is the take home message for surgeons?Rodrigo Modolo, Carlos Collet, Yoshinobu Onuma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 25, 2016
Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imagingYohei Sotomi, Pannipa Suwannasom, Patrick W Serruys, et al.
Pharmacological Research|March 15, 2008
The future of drug-eluting stentsNeville Kukreja, Yoshinobu Onuma, Joost Daemen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 28, 2017
State of the art: the inception, advent and future of fully bioresorbable scaffoldsYuki Katagiri, Gregg W Stone, Yoshinobu Onuma, et al.
Expert Opinion on Drug Delivery|August 24, 2016
The Absorb bioresorbable vascular scaffold for the treatment of coronary artery diseaseCarlos Collet, Robbert J de Winter, Yoshinobu Onuma, et al.
Expert Review of Medical Devices|March 17, 2012
Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectivesSalvatore Brugaletta, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
Pageof 67

Showing results (1-10 of 665) with videos related to

Sort By:
Pageof 67
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2017
Long-term data of BRS presented at EuroPCR 2017 (Friday, 19 May)Patrick W Serruys, Athanasios Katsikis, Yoshinobu Onuma
Expert Review of Medical Devices|May 8, 2009
Xience V everolimus-eluting coronary stentNeville Kukreja, Yoshinobu Onuma, Patrick W Serruys
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 24, 2013
Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trialYoshinobu Onuma, Karine Miquel-Hebert, Patrick W Serruys, et al.
Expert Opinion on Drug Delivery|February 26, 2009
Advances in stent drug delivery: the future is in bioabsorbable stentsJoanna J Wykrzykowska, Yoshinobu Onuma, Patrick W Serruys
Annals of Cardiothoracic Surgery|August 11, 2018
SYNTAX II and SYNTAX III trials: what is the take home message for surgeons?Rodrigo Modolo, Carlos Collet, Yoshinobu Onuma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 25, 2016
Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imagingYohei Sotomi, Pannipa Suwannasom, Patrick W Serruys, et al.
Pharmacological Research|March 15, 2008
The future of drug-eluting stentsNeville Kukreja, Yoshinobu Onuma, Joost Daemen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 28, 2017
State of the art: the inception, advent and future of fully bioresorbable scaffoldsYuki Katagiri, Gregg W Stone, Yoshinobu Onuma, et al.
Expert Opinion on Drug Delivery|August 24, 2016
The Absorb bioresorbable vascular scaffold for the treatment of coronary artery diseaseCarlos Collet, Robbert J de Winter, Yoshinobu Onuma, et al.
Expert Review of Medical Devices|March 17, 2012
Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectivesSalvatore Brugaletta, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
Pageof 67